je.st
news
Merck Completes Sale of Consumer Care Business to Bayer AG for $14.2 Billion
2014-10-01 17:30:00| Merck.com - Corporate News
Dateline City: WHITEHOUSE STATION, N.J. Worldwide Collaboration to Market and Develop Portfolio of Soluble Guanylate Cyclase (sGC) Modulators Commences WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, said today it has completed the previously announced sale of the Merck Consumer Care (MCC) business to Bayer AG. Language: English Contact: MerckMedia:Pamela Eisele, 267-305-3558Steve Cragle, 908-423-3461Investor:Joe Romanelli, 908-423-5185Justin Holko, 908-423-5088 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: business
care
sale
consumer
Category:Biotechnology and Pharmaceuticals